Author’s Comment: HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory

TRON is delighted to announce an article published in Oncoimmunology.  TRON co-author Nadja Salomon shares this Author’s Comment. HPV16 infections are associated with a variety of cancers and there is compelling evidence that the transforming activity of HPV16 critically depends on the expression of the viral oncoproteins E6 and E7. Therapeutic cancer vaccines capable of

Continue Reading

TRON scientists publish in Oncoimmunology

Mainz, July 19, 2019 – TRON scientists publish in Oncoimmunology TRON has published an article on the immunomodulatory effects of the TLR7 agonist SC1 in Oncoimmunology.  Among the exciting results, the authors show that SC1 administration leads to inhibition of tumor growth and prolonged survival, and that this effect is dependent on CD8+ T cells. 

Continue Reading

Healthcare Hackathon Mainz

At the Healthcare Hackathon at the University Medical Center Mainz, experts from the field of healthcare met with startups, programmers, and industry partners. In interdisciplinary mixed teams, technology-based solutions were developed for practical challenges in hospitals and care. For TRON, Jonas Ibn-Salem participated in the hackathon and worked with experts from IBM, Garmin, BioNTech and

Continue Reading

CIMT 2019 Poster Award

At the annual meeting of the Association for Cancer Immunotherapy (CIMT) in 2019, six scientists received the CIMT Poster Award. Thomas Rösler, a scientist from TRON, won the prize in the category ‘Therapeutic Vaccination’ for his work ‘Modelling immunogenicity with omics data integration’ (Abstract 37). He presented his algorithm TOPAZ, which defines candidates for cancer

Continue Reading

CIMT 2019 Annual Meeting

The Association for Cancer Immunotherapy CIMT’s Annual Meeting brings the world’s top cancer biology and immunotherapy researchers together in the heart of Europe.  The 2019 Annual Meeting will take place May 21-23 at the Rheingoldhalle Congress Center in Mainz.

Continue Reading

Hohe Auszeichnung für Mainzer Krebsforscher

Professor Ugur Sahin erhält den Deutschen Krebspreis 2019 Mainz, 28. Februar 2019 – Univ.-Prof. Dr. Ugur Sahin hat den Deutschen Krebspreis 2019 erhalten – eine der angesehensten Auszeichnungen in der Krebsmedizin in Deutschland. Prof. Sahin erhält den Preis in der Kategorie Transferforschung für seine wegweisenden Arbeiten zu individualisierten Krebsimmuntherapien, insbesondere für die Entwicklung und klinische

Continue Reading

At the top of the world with personalized cancer immunotherapy

Official foundation ceremony of HI-TRON Mainz Mainz, February 14, 2019 – The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) is to become one of the world’s leading centers for personalized cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and the Research Institute Translational Oncology (TRON gGmbH)

Continue Reading

TRON celebrates young talent

Mainz, January 31, 2019 – TRON celebrates young talent TRON is sponsoring two scholarships in the Deutschlandstipendium 2018/2019 of the Johannes Gutenberg University Mainz, thereby supporting two young medical students as part of this Federal Ministry of Education and Research program. On January 31st, the festive dinner for Deutschlandstipendium sponsors and scholarship holders took place

Continue Reading

Ugur Sahin at 1st German Cancer Research Congress

Mainz, February 5, 2019 – The 1st German Cancer Research Congress (GCRC) is taking place in Heidelberg 4-5 February, showcasing the best cancer research in Germany.   Ugur Sahin will speak in the session on Tumor Immunology and Immunotherapy on Tuesday, February 5th.   For more information on this event, please see the official DKFZ website.

Continue Reading